Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

Although immune checkpoint inhibitors have improved the overall survival rate of skin cutaneous melanoma (SKCM) patients, there is a wide variation and low response rate to these treatments in clinical immunotherapy for melanoma patients. These problems can be addressed through the induction of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yajun, Cai, Qinqin, Xie, Xiaolin, Gao, Shilong, Fan, Xiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677727/
https://www.ncbi.nlm.nih.gov/pubmed/36419893
http://dx.doi.org/10.3389/fonc.2022.1011046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677727/
https://www.ncbi.nlm.nih.gov/pubmed/36419893
http://dx.doi.org/10.3389/fonc.2022.1011046

Ejemplares similares